Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Glucose monohydrate
B. Braun Melsungen AG.
QB05B
Glucose monohydrate
5 grams/100 millilitres
Solution for infusion
POM: Prescription Only Medicine as defined in relevant national legislation
Cats, Cattle, Dogs, Goats, Horses, Pigs, Sheep
I.V. SOLUTIONS
Electrolytes
Authorised
2012-04-27
Health Products Regulatory Authority 16 February 2022 CRN00CMZ2 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Glucose 5g/100 ml B. Braun Vet Care solution for infusion for cattle, horses, sheep, goats, pigs, dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 100 ml contains: Active substance: Glucose monohydrate 5.5 (equivalent to anhydrous glucose 5.0) For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Solution for infusion Clear, colourless or almost colourless aqueous solution, free from visible particles Caloric value 837 kJ/l = 200 kcal/l Theoretical osmolarity 278 mOsm/l pH value 3.5 - 5.5 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, horses, sheep, goats, pigs, dogs and cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cattle, horses, sheep, goats, pigs, dogs and cats: - Treatment of dehydration (in the absence of shock) - Parenteral rehydration - Correction of hypernatremia - Correction of hyperkalaemia - Transient supportive treatment of hypoglycaemia 4.3 CONTRAINDICATIONS Do not administer to hyperglycaemic animals. This product is unsuitable for the correction of hypotonic dehydration. Do not use in animals with pre-existing peripheral oedema caused by a reduction in intravascular oncotic pressure. This product is not suitable as a sole source of calorie requirements or as a substitute for oral or parenteral nutrition. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals This product does not contain electrolytes. Care should be taken to closely monitor electrolyte and phosphate balance in patients undergoing infusion of this product, and to adjust treatment accordingly. This product should be used with particular caution in patients with the following conditions: Health Products Regulatory Authority 16 February 2022 CRN00CMZ2 Page 2 of 4 Diabetes mellitus Intracranial or intraspinal bleeding Anuria Addisons disease Severe or long standing hypernatraem Prečítajte si celý dokument